POPULATION PK AND EXPOSURE-RESPONSE ANALYSES OF APREMILAST IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Kassir, N. [1 ]
Savant, I. [2 ]
Mouksassi, M. S. [1 ]
Marier, J. F. [1 ]
Zhu, W. [2 ]
Lau, H. [2 ]
机构：
[1] Pharsight Corp, Montreal, PQ, Canada
[2] Celgene Corp, Summit, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [31] Exposure-response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis
    Khatri, Amit
    Klunder, Ben
    Peloso, Paul M.
    Othman, Ahmed A.
    RHEUMATOLOGY, 2019, 58 (02) : 352 - 360
  • [32] Population Approach for Exposure-Response Modeling of Golimumab in Patients With Rheumatoid Arthritis
    Hu, Chuanpu
    Xu, Zhenhua
    Zhang, Yi
    Rahman, Mahboob U.
    Davis, Hugh M.
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 639 - 648
  • [33] Exposure-Response Analyses of Upadacitinib Effects on Plasma Biomarkers in Rheumatoid Arthritis Patients
    Qian, Yuli
    Cai, Fang
    Sornasse, Thierry
    Shen, Jie
    Camp, Heidi
    Mohamed, Mohamed-Eslam
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 584 - 585
  • [34] BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Kourlaba, G.
    Batsi, M.
    Vostitsanou, Z.
    Maniadakis, N.
    VALUE IN HEALTH, 2018, 21 : S424 - S424
  • [35] BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS IN GREECE
    Guo, W.
    Han, S.
    Zhang, Y.
    VALUE IN HEALTH, 2018, 21 : S424 - S424
  • [36] Lagging Exposure Information in Cumulative Exposure-Response Analyses
    Richardson, David B.
    Cole, Stephen R.
    Chu, Haitao
    Langholz, Bryan
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 174 (12) : 1416 - 1422
  • [37] Population pharmacokinetic and exposure-response analyses of guanfacine in Japanese pediatric ADHD patients
    Tsuda, Yoshiyuki
    Matsuo, Yumiko
    Matsumoto, Sayaka
    Wajima, Toshihiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (06) : 365 - 371
  • [38] Population Pharmacokinetics and Exposure-Response Analyses of an MDM2 Inhibitor Milademetan
    Kang, Dongwoo
    Kumar, Prasanna
    Zernovak, Oleg
    Song, Saeheum
    Xiong, Yuan
    Bergsma, Tim
    Lovern, Mark
    Yin, Ophelia
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S24 - S24
  • [39] EXPOSURE-RESPONSE ANALYSES OF UPADACITINIB EFFICACY AND SAFETY IN RHEUMATOID ARTHRITIS - ANALYSES OF PHASE 2 AND 3 STUDIES
    Mohamed, Mohamed-Eslam
    Nader, Ahmed
    Winzenborg, Insa
    Doelger, Eva
    Noertersheuser, Peter
    Pangan, Aileen
    Othman, Ahmed
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 739 - 740
  • [40] Dioxin: Exposure-response analyses and risk assessment
    Steenland, K
    Deddens, J
    INDUSTRIAL HEALTH, 2003, 41 (03) : 175 - 180
12345